Matt Dellatorre

Stock Analyst at Goldman Sachs

(2.45)
# 2,515
Out of 5,032 analysts
2
Total ratings
100%
Success rate
12.42%
Average return

Stocks Rated by Matt Dellatorre

Viatris
Jun 6, 2025
Initiates: Neutral
Price Target: $10
Current: $10.17
Upside: -1.67%
Teva Pharmaceutical Industries
Jun 6, 2025
Initiates: Buy
Price Target: $24
Current: $19.31
Upside: +24.29%